CS logo
small CS logo
Aspirus Heart and Vascular Institute - Research and Education

Wausau, Wisconsin, United States
Vascular surgeon in Wausau, Wisconsin
425 Pine Ridge Blvd Suite 209, Wausau, WI 54401

About Aspirus Heart and Vascular Institute - Research and Education


"Aspirus is a non-profit, community-directed health system based in Wausau, Wisconsin. Its 7,700 employees are focused on improving the health and well-being of people throughout Wisconsin and Upper Michigan. Aspirus serves communities through four hospitals in Upper Michigan and four hospitals in Wisconsin, more than 50 clinics, home health and hospice care, pharmacies, critical care and air-medical transport, medical goods, nursing homes and a broad network of physicians. Aspirus was recognized by IBM Watson Health as a Top 15 Health System in its 2018 annual study identifying the top-performing health systems in the country."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials

Clinical Trials at Aspirus Heart and Vascular Institute - Research and Education


During the past decade, Aspirus Heart and Vascular Institute - Research and Education conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
1999-05-01
2017-07-19
Completed
475
Evaluation of Intravenous Levosimendan Efficacy in the Short Term Treatment of Decompensated Chronic Heart Failure.
2002-09-01
2004-12-01
Completed
600
Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer
2005-03-01
Completed
623
Study to Compare the Efficacy and Safety of CC-5013 vs. Placebo in Subjects With Metastatic Malignant Melanoma.
2002-10-01
2005-07-15
Completed
274
Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
2003-11-03
2025-12-01
Active, not recruiting
2,672
S0230 Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
2003-10-01
2016-09-01
Completed
257
Study of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer
2005-05-01
Completed
520
Carboplatin in Treating Patients With Stage IC-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
2004-03-01
2010-07-01
Completed
1,300

Rows per page:

1–100 of 176

Clinical Trials Sponsors and Collaborators


Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Aspirus Heart and Vascular Institute - Research and Education


According to Clinical.Site data, the most researched conditions in "Aspirus Heart and Vascular Institute - Research and Education" are "Coronary Artery Disease" (2 trials), "Atherosclerosis of Native Arteries of the Extremities" (1 trials) and "Stroke" (1 trials). Many other conditions were trialed in "Aspirus Heart and Vascular Institute - Research and Education" in a lesser frequency.

Clinical Trials Intervention Types at Aspirus Heart and Vascular Institute - Research and Education


Most popular intervention types in "Aspirus Heart and Vascular Institute - Research and Education" are "Device" (4 trials) and "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "3 months of dual antiplatelet therapy (DAPT)" (1 trials), "Aspirin" (1 trials), "ELUVIA (Stent Implantation)" (1 trials), "PROMUS Coronary Stent System" (1 trials) and "PROMUS Element Coronary Stent System" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Aspirus Heart and Vascular Institute - Research and Education


The vast majority of trials in "Aspirus Heart and Vascular Institute - Research and Education" are 4 trials for "All" genders.

Clinical Trials Status at Aspirus Heart and Vascular Institute - Research and Education


Currently, there are NaN active trials in "Aspirus Heart and Vascular Institute - Research and Education". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Aspirus Heart and Vascular Institute - Research and Education, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Aspirus Heart and Vascular Institute - Research and Education, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status